Categories
Locations
Alabama
Alaska Alberta Arizona Arkansas British Columbia California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisana Maine Manitoba Maryland/DC Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Brunswick New Hampshire New Jersey New Mexico New York Newfoundland & Labrador North Carolina North Dakota Northwest Territories Nova Scotia Nunavut Ohio Oklahoma Ontario Oregon Pennsylvania Prince Edwards Island Quebec Rhode Island Saskatchewan South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming Yukon ISO Standards
13485
13485:2003 14000 14001 14001:2004 17025 17025:2005 18001 9000 9000:2000 9000:2001 9000:2008 9001 9001:2000 9001:2001 9001:2008 9001:2015 9002 AS9100 AS9100:2009 AS9100:2009C AS9100B AS9100C QS9000 TS16949 TS16949:2002 TS16949:2009 Specialty
Woman Owned
Minority Owned Veteran Owned Ownership
All Types
Public Private Distribution
All Areas
International National Regional Local Searching IndustryNet for drug candidate suppliers.Related Searches:
|
Drug Candidates PharmaceuticalsOTHER SUPPLIERS
IndustryNet is the industrial marketplace (Page 1 of 2)
List of verified suppliers of smoking cessation aid drug candidates in Phase II & Phase III clinical trials & contract manufacturing of private label cigarettes, biopharmaceutical drug candidates for cancer & inflammatory & immunological diseases in Phase II clinical trials, gene therapy candidates for the treatment of ocular diseases in Phase II & III clinical trials, biopharmaceutical drug candidates in Phase I, investigational RNAi therapeutic pharmaceutical drug candidates in Phase III clinical trials for the treatment of rare diseases, drug candidates for Alzheimer's disease in Phase II clinical trials, enhanced therapeutic drug candidates for certain cancers, infectious diseases & CNS disorders, pharmaceutical immuno-oncology drug candidates in preclinical & Phase I & II clinical trials, II & pivotal clinical trials for treatment of hereditary angioedema & Ebola & Marburg virus infections, drug candidates for treatment of infectious diseases, novel oral & intravenous drug candidates in preclinical & Phase I clinical trials for the treatment of serious & life-threatening invasive fungal infections in humans, biopharmaceutical drug candidates in Phase I & II clinical trials, analytical & formulation development, cGMP manufacturing, labeling & distribution, pharmaceutical drug candidates for dermatology, anti-inflammatory & antibiotic applications, differentiated antibiotic drug candidates for treating antibiotic-resistant pathogens in Phase II & Phase III clinical trials, pharmaceutical drug candidates in Phase III clinical trials for severe diseases caused by excess or irregular cortisol levels, anticancer drug candidates in Phase III clinical trials, biopharmaceutical small molecule kinase inhibitor drug candidartes in Phase II trials for the treatment of cancer, cancer treatment therapy drugs & CLIA-certified predictive diagnostics for guiding treatment of blood cancers, oncology drug candidates in Phase II & III clinical trials, pharmaceutical drug candidates in clinical trials, neoantigen-based oncological immunotherapy product candidates in Phase I clinical trials, fibrotic diseases, pharmaceutical drug discovery & development for the treatment of cancers, engineered anticancer antibodies in Phase I-III clinical trials, a therapeutic drug candidate to treat celiac disease, clinical-stage CRISPR-based novel, pharmaceutical drug candidates for metastatic cancers in Phase II clinical trials, biopharmaceutical drug candidates for the treatment of cancer.
Need help? IndustryNet is powered by real people. Contact us for assistance.
|